NCT07112066View on ClinicalTrials.gov

Multimodality Cardiac Imaging for Disease Progression in ATTR-CM

NANot yet recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2027

Conditions
Amyloidosis Cardiac
Interventions
DIAGNOSTIC_TEST

FAPI tracer

18F-FAPI-74 PET/CT, cardiac MRI, echocardiography and blood sample for BMP5 serum concetration is performed at baseline and 12-month follow-up.

All Listed Sponsors
collaborator

Olga Mayenfisch Stiftung, Zurich, Switzerland

UNKNOWN

collaborator

University of Zurich

OTHER

lead

Dominik Benz

OTHER

NCT07112066 - Multimodality Cardiac Imaging for Disease Progression in ATTR-CM | Biotech Hunter | Biotech Hunter